Aceso Biosciences – an Essentia BioSciences business – was recently recognised at the Bury Free Press West Suffolk Business Awards 2025 for fast-tracking potential treatment of Type 1 Diabetes in the first instance and the Type 2 element of the disease longer term.
For CP Packaging, The EpiCentre is more than a workspace, it’s a launchpad for ideas and collaboration. “The environment here sparks new thinking,” says Kem Gokay. With plans to grow their team locally, the company is set to scale with purpose, driven by innovation and community.
In 2019, SKC Studios became the very first company to join us at The EpiCentre, setting the stage for a partnership that would help shape the future of innovation in Haverhill and beyond. Over the past five years, we have proudly watched SKC Studios evolve from a creative game development studio into a pioneering force in AI-powered customer engagement. Their flagship product, 1956 Individuals, an AI-powered platform of emotionally intelligent avatars, is redefining how people interact with information and experience brands.
From day one, KluraLabs has been guided by purpose. Their team of scientists and engineers, many holding PhDs in materials science, chemistry, and microbiology, are developing a new generation of antimicrobial technologies built on sustainable, non-toxic ingredients. These innovations are designed to integrate seamlessly into existing systems, making them not only effective but scalable and commercially viable.
Spending the day with Centre Manager, Helen Earl, as well as innovative companies, 1956 Individuals and KluraLabs, they delved into the incredible work that’s happening at The EpiCentre, the advantage of our location and the support that we can offer.
The EpiCentre, managed by Oxford Innovation Space, has celebrated its fifth anniversary, marking five years of supporting entrepreneurs, start-ups and growing businesses in the East of England.
Since graduating from The EpiCentre in March 2022, Amphista has established itself at Granta Park, Cambridge, a world-leading hub for biopharmaceutical innovation. Amphista’s mission is to unlock the full potential of Targeted Protein Degradation (TPD) by developing a new generation of transformational medicines using their proprietary Targeted Glue® technology.
MultiplAI Health is redefining the future of healthcare with their ground-breaking RNA-based, AI-driven screening technology. After graduating from The EpiCentre in July 2023, MultiplAI Health has continued to accelerate innovation in early disease detection, developing a simple blood test that transforms how cardiovascular and complex diseases are diagnosed.
K9 Digital stands out as a creative powerhouse within The EpiCentre’s vibrant community. Founded by industry veterans with a passion for character creation, K9 Digital specialises in 3D character, creature, and animal art for games, VR, TV, and film.
PES Technologies embodies the pioneering spirit at the heart of The EpiCentre community. After graduating from the centre in May 2025, PES Technologies has continued to make waves in the agri-tech sector, driven by their mission to revolutionise soil health measurement.
Join an inspiring community of innovators and entrepreneurs.
Stay in touch with what’s happening at The EpiCentre. Pop in your details below and confirm you’re happy for us to send you emails, and we’ll keep you up to date with all that’s happening at The EpiCentre.
Disclaimer: The EpiCentre uses the information you provide on this form to get in touch with you and provide updates and for marketing purposes. You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us. We treat all personal information with respect. By subscribing, you agree that we may process your information in accordance with these terms.
Space to experiment, space to research
Space to experiment, space to research
Update – 11 August 2022
Our Innovation Centres remain operational and accessible, and provide a safe environment for our staff and customers. We continue to assess the risk of COVID-19 alongside the latest guidance from government. In the meantime our Innovation Centre remains COVID-19 Secure and fully open for business. Our detailed risk assessment can be found here.
